Humanized mice for the study of hepatitis C;Des souris humanisées pour i'étude du virus de i'hépatite C

Medecine/Sciences

Volumn 27, Issue 6-7, 2011, Pages 587-589

  Gilgenkrantz, Hélène ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; DNA BINDING PROTEIN; FAHD2A PROTEIN, MOUSE; FK 506 BINDING PROTEIN; HYDROLASE; RAG2 PROTEIN, MOUSE; UROKINASE;

ANIMAL; ARTICLE; CHEMISTRY; DIMERIZATION; DISEASE MODEL; DISEASE PREDISPOSITION; FETAL TISSUE TRANSPLANTATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER; LIVER CELL; MOUSE; MOUSE MUTANT; PHYSIOLOGY; PRENATAL DEVELOPMENT; RADIATION CHIMERA; TRANSGENIC MOUSE; TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TYROSINEMIA; VIROLOGY; VIRUS REPLICATION; XENOGRAFT;

ANIMALS; CASPASE 3; CASPASE 8; DIMERIZATION; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DNA-BINDING PROTEINS; FETAL TISSUE TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; HYDROLASES; LIVER; MICE; MICE, SCID; MICE, TRANSGENIC; RADIATION CHIMERA; TACROLIMUS BINDING PROTEINS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TYROSINEMIAS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VIRUS REPLICATION;

HEPATITIS C VIRUS; MUS;

EID: 79960945072     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2011276009     Document Type: Article

References (11)

1. Nan E, Burakova T, Dagan S, et al. The hepatitis B virus-tnmera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 1999;29:553-62. (Pubitemid 29088462)
2. Eren R, Landstein D, Terlaeltaub D, et al. Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients. J Virol 2006;80:2654-64. (Pubitemid 43346361)
3. Dandri M, Burda MR, Torok E, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001;33:981-8. (Pubitemid 32246649)
4. Kneteman NM, Werner AJ, O'Connell J, et al. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology 2006;43:1346-53. (Pubitemid 43980114)
5. Waters L, Nelson M. New therapeutic options for hepatitis C. Curr Opin Infect Dis 2006;19:615-22. (Pubitemid 44665469)
6. Bissig KD, Wieland SF, Tran P, et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clm Invest 2010;120:924-30.
7. Washburn ML, Bility MT, Zhang L, et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011;140:1334-44.
8. Mallet VO, Mitchell C, Guidotti JE, et al. Conditional cell ablation by tight control of caspase-3 dimenzation in transgenic mice. Nat Biotechnot 2002;20:1234-39. (Pubitemid 35462488)
9. Rosenberg AR, Carpentier A, Podevin P. Enfin un modele de culture du virus de I'hépatite C adapté aux hepatocytes humains pnmaires ! Med Set (Pans) 2010;26:1013-4.
10. Legrand-Abravanel F, Izopet J. Culture du virus de I'hepatite C, enfin ! Med Sci (Pans) 2007;23:588-9.
11. Touboul T, Vallier L, Weber A. Cellules souches embryonnaires humaines et iPS - Une source fiable d'hepatocytes fcetaux. Med Set (Paris) 2010;26:1061-6.